TENON MEDICAL INC (TNON)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$3.72-1.33%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · TNON
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|---|
| Revenues | |||||||
| Revenues | 5.3 | 3.9 | 3.3 | 2.9 | 0.7 | 0.2 | — |
| Total Revenues | 5.3 | 3.9 | 3.3 | 2.9 | 0.7 | 0.2 | — |
| Cost of Revenues | 1.8 | 1.6 | 1.6 | 1.7 | 1.3 | 0.1 | — |
| Gross Profit | 3.5 | 2.4 | 1.7 | 1.2 | (0.6) | 0.1 | — |
| Operating Expenses & Income | |||||||
| R&D Expenses | 2.4 | 2.1 | 2.6 | 3.2 | 2.8 | 1.7 | — |
| Operating Income | (12.9) | (12.8) | (13.8) | (15.7) | (18.7) | (6.5) | — |
| Earnings from Continuing Operations | |||||||
| Interest Expense | — | — | 0.0 | 0.0 | 0.4 | — | — |
| Other Non-Operating Income / Expenses | (0.8) | 0.2 | 0.1 | 0.1 | (0.2) | (0.6) | — |
| EBT, Incl. Unusual Items | — | — | — | — | (18.9) | (7.1) | — |
| Earnings from Continuing Operations | — | (12.6) | (13.7) | (15.6) | (18.9) | — | — |
| Net Income | |||||||
| Minority Interest | — | — | — | — | 0.0 | (0.0) | — |
| Net Income | (13.7) | (12.6) | (13.7) | (15.6) | (18.9) | (7.0) | — |
| Per Share | |||||||
| Basic EPS | (41,759.15) | (1.70) | (11.26) | (68.64) | (23.62) | (7.81) | — |
| Diluted EPS | (41,759.15) | (1.70) | (11.26) | (68.64) | (23.62) | (7.81) | — |
| Revenue per Share | 16,195.12 | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Diluted Weighted Avg Shares | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — |
| Supplemental | |||||||
| EBITDA | — | (12.5) | (13.4) | (15.5) | (18.6) | — | — |
| EBIT | (12.9) | (12.8) | (13.8) | (15.7) | (18.7) | (6.5) | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.